<?xml version="1.0" encoding="UTF-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 C:\PWang\Datasets\grobid-0.5.5\grobid-0.5.5\grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<encodingDesc>
			<appInfo>
				<application version="0.5.5" ident="GROBID" when="2020-06-22T14:04+0000">
					<ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
				</application>
			</appInfo>
		</encodingDesc>
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9)</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">David</forename><forename type="middle">J</forename><surname>Weber</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Hospital Epidemiology</orgName>
								<orgName type="institution">University of North Carolina Health Care</orgName>
								<address>
									<settlement>Chapel Hill</settlement>
									<region>NC</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Division of Infectious Diseases</orgName>
								<orgName type="institution">University of North Carolina School of Medicine</orgName>
								<address>
									<addrLine>Chapel Hill</addrLine>
									<region>NC</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">William</forename><forename type="middle">A</forename><surname>Rutala</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Hospital Epidemiology</orgName>
								<orgName type="institution">University of North Carolina Health Care</orgName>
								<address>
									<settlement>Chapel Hill</settlement>
									<region>NC</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Division of Infectious Diseases</orgName>
								<orgName type="institution">University of North Carolina School of Medicine</orgName>
								<address>
									<addrLine>Chapel Hill</addrLine>
									<region>NC</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">William</forename><forename type="middle">A</forename><surname>Fischer</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Division of Pulmonary and Critical Care Medicine</orgName>
								<orgName type="institution">University of North Carolina School of Medicine</orgName>
								<address>
									<settlement>Chapel Hill</settlement>
									<region>NC</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Hajime</forename><surname>Kanamori</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Hospital Epidemiology</orgName>
								<orgName type="institution">University of North Carolina Health Care</orgName>
								<address>
									<settlement>Chapel Hill</settlement>
									<region>NC</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Division of Infectious Diseases</orgName>
								<orgName type="institution">University of North Carolina School of Medicine</orgName>
								<address>
									<addrLine>Chapel Hill</addrLine>
									<region>NC</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Emily</forename><forename type="middle">E</forename><surname>Sickbert-Bennett</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Hospital Epidemiology</orgName>
								<orgName type="institution">University of North Carolina Health Care</orgName>
								<address>
									<settlement>Chapel Hill</settlement>
									<region>NC</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Division of Infectious Diseases</orgName>
								<orgName type="institution">University of North Carolina School of Medicine</orgName>
								<address>
									<addrLine>Chapel Hill</addrLine>
									<region>NC</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9)</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="DOI">10.1016/j.ajic.2015.11.018</idno>
					<note>Major article</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>The discovery that the 1976 outbreak of pneumonia (Legionnaires' disease) was caused by a newly described bacteria, Legionella spp, was an awakening call for public health and infection control professionals. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b3">4</ref> The first reports of the disease later known as AIDS in 1978 <ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b5">6</ref> and the discovery of the virus that causes AIDS, <ref type="bibr" target="#b6">7</ref> now known as HIV, in 1983 further demonstrated that infectious diseases would continue to be a major source of morbidity and mortality for patients. Importantly, although Legionella spp turned out not to be a new human pathogen but one that had caused human diseases for centuries, HIV was a new pathogen to humans, and its origin was traced to simian immunodeficiency viruses in primates. <ref type="bibr" target="#b7">8</ref> The public health threats posed by emerging diseases have been well described in 2 reports from the Institute of Medicine, one in 1992 and one in 2001. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b9">10</ref> Since the discovery of Legionella and HIV, many emerging infectious diseases have had important infection control implications. This review will focus on several of the most important threats, including novel coronaviruses (severe acute respiratory disease <ref type="bibr">[SARS]</ref> and Middle East respiratory syndrome <ref type="bibr">[MERS]</ref>), hemorrhagic viruses (Lassa, Ebola), and novel influenza viruses, and the infection control strategies required to mitigate the associated public health threat posed by these viruses.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EMERGING INFECTIOUS DISEASES</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Definitions</head><p>The World Health Organization defines an emerging infectious disease as "one that has appeared in the population for the first time, or that may have existed previously but is rapidly increasing incidence or geographic range." <ref type="bibr" target="#b10">11</ref> The Centers for Disease Control and Prevention (CDC) define emerging infectious diseases as follows <ref type="bibr" target="#b11">12</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>:</head><p>• New infections resulting from changes in or evolution of existing organisms.</p><p>• Known infections spreading to new geographic areas or populations.</p><p>• Previously unrecognized infections appearing in areas undergoing ecologic transformation.</p><p>• Old infections re-emerging as a result of antibiotic resistance in known agents or breakdowns in public health measures.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Factors in the emergence of infectious diseases</head><p>In 1985, Wilson described the basic concepts in infectious disease emergence as follows <ref type="bibr" target="#b12">13</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>:</head><p>• Emergence of infectious diseases is complex.</p><p>• Infectious diseases are dynamic.</p><p>• Most new infections are not caused by genuinely new pathogens.</p><p>• Agents involved in new and re-emergent infections cross taxonomic lines to include viruses, bacteria, fungi, protozoa, and helminths.</p><p>• The concept of the microbe as the cause of disease is inadequate and incomplete.</p><p>• Human activities are the most potent factors driving disease emergence.</p><p>• Social, economic, political, climactic, technologic, and environmental factors shape disease patterns and influence emergence.</p><p>• Understanding and responding to disease emergence require a global perspective, conceptually and geographically.</p><p>• The current global situation favors disease emergence.</p><p>An important concept listed by Wilson is that most new and emerging infections are zoonotic diseases that have jumped taxonomic lines to infect humans. Of the approximately 1,400 known human pathogens, 58% are zoonotic, including 73% of the 117 that meet the definition for emerging or re-emerging infectious pathogens.</p><p>14 Importantly, all of the pathogens that are the focus of this article are zoonotic. A more complete list of pathogens considered to have emerged via a species jump have been published. <ref type="bibr" target="#b14">15</ref> Karesh et al have reviewed how zoonotic diseases result from natural pathogen ecology and how other circumstances, such as animal production, extraction of natural resources, and antimicrobial application, change the dynamics of disease exposure to human beings. <ref type="bibr" target="#b15">16</ref> The stages in emergence of pandemic zoonotic diseases have also been reviewed. <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref> Morse et al described 3 stages in emergence of zoonotic diseases: (1) pre-emergence (encroachment into wildlife habitat and change in land use); (2) localized emergence (expansion of the wildlife-human being interface, for example Ebola virus); and (3) pandemic emergence (international travel, for example SARS, HIV and AIDS). <ref type="bibr" target="#b17">18</ref> Pike et al described 5 stages in zoonotic disease emergence: (1) exclusive to animals; (2) primary human infections only; (3) limited human-to-human transmission; (4) sustained human-to-human transmission; and (5) exclusive to humans. <ref type="bibr" target="#b16">17</ref> The 1992 Institute of Medicine report on microbial threats listed the factors in infectious disease emergence as follows: (1) ecological changes, including those caused by economic development and land use (agriculture: dams, changes in water ecosystems; deforestation/reforestation; flood-drought; famine; climate changes); (2) human demographics and behavior (societal events: population growth and migration; war or civil conflicts; urban decay; sexual behavior; intravenous drug use; use of high-density facilities); (3) international travel and commerce (worldwide movement of goods and people; air travel); (4) technology and industry (globalization of food supplies; changes in food processing and packaging; organ or tissue transplantation; drugs causing immunosuppression; widespread use of antibiotics); (5) microbial adaptation and change (microbial evolution, response to selection in the environment); and (6) breakdown in public health measures (curtailment or reduction in prevention programs; inadequate sanitation and vector control measures). <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b19">20</ref> A more recent article listed the following factors as influencing new and re-emerging infections: exotic pets, exotic foods (eg, bush meat), companion animals, alterations in livestock management, acquisition of new virulence factors, pathogen adaptation to new host species, changes in land use, tourism, translocation of infected animals or persons, and climate changes influencing arthropods.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>21</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EMERGING INFECTIOUS DISEASES OF INFECTION CONTROL IMPORTANCE</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Overview</head><p>In the last 35 years, many emerging infectious diseases of infection control importance have been described <ref type="table" target="#tab_0">(Table 1)</ref>. <ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref>  Diseases of infection importance included Legionella, <ref type="bibr" target="#b24">25</ref> HIV, variant Creutzfeldt-Jakob disease, <ref type="bibr" target="#b25">26</ref> West Nile virus disease, <ref type="bibr" target="#b26">27</ref> SARS, monkeypox, <ref type="bibr" target="#b27">28</ref> MERS, and Ebola virus disease (EVD). These diseases are of infection control importance because they are spread person-to-person (HIV, SARS, monkeypox, MERS, and EVD), health care personnel (HCP) may be at substantial risk of acquiring infection during patient care (HIV, SARS, monkeypox, MERS, and Ebola), they may be transmitted by blood transfusions (HIV, variant Creutzfeldt-Jakob disease, and West Nile virus), or they have the potential to cause outbreaks in health care facilities (Legionella, SARS, MERS, and EVD). Screening of donated blood has largely eliminated transmission of HIV and West Nile via blood transfusions. Interestingly, although most of the emerging diseases are endemic in lesser developed countries, 5 developed countries (United States, United Kingdom, Australia, Japan, and Germany) accounted for the most reports of emerging disease events. <ref type="bibr" target="#b28">29</ref> The emergence of anti-infective resistance among microbes has also been an emerging threat in U.S. health care facilities. The most important microorganisms have included methicillin-resistant Staphylococcus aureus, <ref type="bibr" target="#b29">30</ref> vancomycin-resistance enterococci, <ref type="bibr" target="#b30">31</ref> extendedspectrum β-lactamase-producing enteric gram-negative bacilli (especially Escherichia coli, Klebsiella, and Enterobacter), <ref type="bibr" target="#b31">32</ref> and carbapenem-resistance Enterobacteriaceae. <ref type="bibr" target="#b32">33</ref> Pathogens with enhanced virulence in recent years have included Clostridium difficile (BI/NAP1/027) <ref type="bibr" target="#b33">34</ref> and norovirus (GII.4 strains). <ref type="bibr" target="#b34">35</ref> Also of concern are continued outbreaks of vaccine-preventable diseases, mumps <ref type="bibr" target="#b35">36</ref> and measles, <ref type="bibr" target="#b36">37</ref> and the resurgence of pertussis. <ref type="bibr" target="#b37">38</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Key considerations in assessing and managing the threat of emerging infectious diseases in health care facilities</head><p>Assessing and managing the threat of an emerging infectious disease requires an understanding of the biology of the pathogen, its epidemiology, the clinical manifestations of infection, the methods of diagnosis, and therapies (if available). In addition, there are a number of issues more specific to infection control ( <ref type="table" target="#tab_1">Table 2</ref>). Key information on the infectious diseases discussed in detail in this article is provided in <ref type="table" target="#tab_2">Table 3</ref>.</p><p>All health care facilities should have a highly communicable disease management plan <ref type="table">(Table 4)</ref>. A detailed discussion of each of these components is beyond the scope of this article. Detailed information is best found, especially early in an epidemic, on the Web pages of local and state health departments, the Centers of Disease Control and Prevention, and the World Health Organization. General recommendations have been provided by infection control experts. <ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref><ref type="bibr" target="#b43">[44]</ref> There are 2 areas that place a health care facility and the personnel at substantial risk for disease acquisition and transmission. First, inadequate screening procedures when patients enter a health care facility can potentially allow transmission from an ill patient to HCP, other patients, or visitors. Second, inadequate supplies of personal protective equipment (PPE) or inadequate training of HCP in proper donning and doffing procedures can increase the risk of exposure for HCP.</p><p>Another important issue is the use of an appropriate antiseptic for hand hygiene and an appropriate surface disinfectant. However, once the nature of the emerging disease is known (ie, bacteria, nonenveloped virus, enveloped virus), it is possible to determine the proper antiseptic and disinfectant, even in the absence of studies of the exact infectious agent. <ref type="bibr" target="#b44">45</ref> For example, an enveloped virus (eg, Lassa, EVD, MERS-CoV, SARS-CoV, influenza A) would be inactivated by any agent active against vegetative bacteria, nonenveloped viruses, or mycobacteria. Any vegetative bacteria would be inactivated by an agent active against a nonenveloped virus or mycobacteria. It is important to remember that alcohol has reduced activity against nonenveloped viruses (eg, norovirus) and no activity against spores (eg, C difficile).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EMERGING INFECTIOUS DISEASES OF SPECIAL INTEREST</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Lassa fever</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Microbiology</head><p>Lassa fever is a single-strand negative RNA virus belonging to the Arenaviridae family. <ref type="bibr" target="#b45">46,</ref><ref type="bibr" target="#b46">47</ref> The family is serologically divided into 2 major complexes: the Old World complex (eg, Lassa virus, Mobala virus) and the New World complex (eg, Junin virus, Machupo virus, Sabia virus). With the exception of the lymphocytic choriomeningitis virus, all virus species show a restricted geographic occurrence. The host for Lassa fever is the multimammate rat (Mastomys natalensis).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Epidemiology</head><p>Lassa fever is endemic in Sub-Saharan West Africa, including Sierra Leone, Liberia, Guinea, and Nigeria. It is estimated that the number of Lassa virus infections per year is West Africa is 100,000-300,000, with approximately 5,000 deaths. Transmission of Lassa virus to humans occurs most commonly through ingestion or inhalation of the virus. Mastomys rodents shed the virus in urine and droppings, and direct contact with these materials through touching soiled objects, eating contaminated food, or exposure to nonintact skin can lead to infection. Person-to-person transmission may occur after exposure to virus in the blood, tissue, secretions, or excretions of a Lassa virus-infected individual. Nosocomial transmission has been common in health care settings where proper PPE or training in the correct use of PPE was not available.</p><p>The incubation period ranges from 6-21 days.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Outbreaks</head><p>In 1969, 3 American missionary nurses became ill in Lassa, Nigeria. Two Yale University laboratory workers studying the disease also became sick. Two of the nurses and one laboratory worker died from what was later identified as Lassa fever. <ref type="bibr" target="#b47">48</ref> Since then, multiple cases of imported Lassa fever have been reported in Europe. <ref type="bibr" target="#b48">49</ref> In addition, multiple imported cases have been reported in the United States. <ref type="bibr" target="#b49">[50]</ref><ref type="bibr" target="#b50">[51]</ref><ref type="bibr" target="#b51">[52]</ref><ref type="bibr" target="#b52">[53]</ref> The most recent imported case in the United States, which occurred in May 2015, died from his infection.</p><p>Since the first description of Lassa fever in 1969, nosocomial transmission has emerged as a prevalent mode of acquisition of infection. <ref type="bibr" target="#b48">49</ref> The largest nosocomial series occurred in Nigeria in 1989, involving 34 cases, including 9 HCP, with a 55% attack rate among patients and a 65% overall fatality rate. <ref type="bibr" target="#b53">54</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical manifestations</head><p>The clinical manifestations of Lassa fever include the gradual onset of fever, nausea, abdominal pain, severe sore throat, cough, conjunctivitis, ulceration of the buccal mucosa, exudative pharyngitis, and cervical adenopathy. <ref type="bibr" target="#b39">40</ref> Late complications include severe swelling of the head and neck and pleural and pericardial effusions. Hemorrhagic complications are less common. Most infections are subclinical or mild, but up to 20% of cases are severe. Importantly, it may be difficult to differentiate Lassa fever from other hemorrhagic fevers in the first 3-7 days of illness because they all present with a similar, influenza-like illness and lack pathognomonic features. <ref type="bibr" target="#b54">55</ref> The overall case fatality rate is approximately 1%, but the observed case fatality rate among hospitalized patients is 15%-20%. The disease is especially severe late in pregnancy, with maternal death or fetal loss occurring in &gt;80% of cases during the third trimester. Deafness occurs in 25% of patients who survive the disease but may return within 1-3 months in half of those affected.</p><p>Lassa fever is most often diagnosed using an enzyme-linked immunosorbent assay. Real-time polymerase chain reaction (PCR) can be used in the early stage of the disease. Intravenous ribavirin has been used successfully to treat patients with Lassa fever. It is most effective when used early in the course of illness. Convalescent plasma has also been used as therapy.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Infection control issues</head><p>Patients with Lassa fever should be placed in a single room on special isolation precautions similar to that used for patients with EVD <ref type="table">(Table 4)</ref>. HCP should wear appropriate PPE similar to that used when caring for patients with EVD, including a full body protective suit with hood, cover gown, 2 sets of gloves, N95 respirator, and face shield or goggles. No published data on environmental survival or germicide susceptibility are available. However, as an enveloped virus, it is likely susceptible to quaternary ammonium compounds, phenolics, and alcohol. <ref type="bibr" target="#b44">45</ref> Lassa virus is considered a class IV biosafety agent; patient samples should only be handled by trained staff and processed in suitably equipped laboratories.</p><p>There is currently no vaccine that protects against Lassa fever. There is no evidence to support the role of ribavirin as postexposure prophylaxis for Lassa fever. <ref type="bibr" target="#b55">56</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EVD</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Microbiology</head><p>Ebola is caused by a nonsegmented, single-strand negative RNA virus of the family Filoviridae. <ref type="bibr" target="#b39">40,</ref><ref type="bibr" target="#b56">57,</ref><ref type="bibr" target="#b57">58</ref> There are 5 identified Ebola virus species, 4 of which are known to cause disease in humans: Zaire, Sudan, Tai Forest (formerly Cote d'Ivoire), and Bundibugyo. The fifth, Reston virus, has caused disease in nonhuman primates, but not in humans.</p><p>The natural reservoir host of Ebola virus remains unknown. However, the detection of antibodies against Ebola and Ebola virus fragments in fruit and insectivore bats are highly suggestive that these animals serve as a reservoir.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Epidemiology</head><p>Past Ebola outbreaks have occurred in West and Central Africa, including the Democratic Republic of the Congo, Uganda, Sudan, and Gabon. <ref type="bibr" target="#b58">[59]</ref><ref type="bibr" target="#b59">[60]</ref><ref type="bibr" target="#b60">[61]</ref> Single cases caused by laboratory accidents have also been reported from Russia and England.</p><p>Once the virus enters the human population, transmission is sustained via person-to-person spread, which is enhanced by the lack of active case finding with isolation or quarantine. The incubation period of Ebola is generally 8-10 days (range, 2-21 days). Infection has been transmitted only from symptomatic persons. <ref type="bibr" target="#b57">58</ref> Ebola is transmitted person-to-person through direct contact (ie, nonintact skin, via mucous membrane contact) with blood, body fluids (eg, urine, saliva, sweat, feces, vomit, breast milk, semen) of an ill person, objects (eg, needles, syringes) that have been contaminated with body fluids from an ill person, or infected fruit bats or primates. More recently, the sexual transmission of this virus has been recognized in Liberia. Recently, cases have been reported in which persons who had recovered from EVD developed recrudescent infection with Ebola virus being recovered from protected body locations, such as eyes and central nervous systems. Ebola is not transmitted through the air or by water. However, in Africa, it may be acquired by handling bushmeat and contact with infected bats. HCP have been a substantial risk for acquiring Ebola through patient care. <ref type="bibr" target="#b58">59</ref> The World Health Organization reported (September 23, 2015 http://www.who.int/csr/disease/ebola/situation-reports/archive/ en/) that since the start of the epidemic in 2014 a total of 881 confirmed cases have occurred in health care providers (from Guinea, Liberia, and Sierra Leone), with 513 reported deaths (58%). HCP in the United States have acquired Ebola during the current outbreak.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Outbreaks</head><p>The first recognized outbreaks of Ebola occurred in West Africa in 1976. In the 40 years since the initial outbreaks in Zaire and Sudan, <ref type="table">Table 4</ref> Preparedness for managing a highly communicable emerging infectious disease</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>General</head><p>• Have a comprehensive facility plan for managing a highly communicable emerging infectious disease.</p><p>• Nestle the plan for emerging infectious diseases within the general disaster plan.</p><p>• Base the plan on the route(s) of transmission for the infectious agent.</p><p>• Incorporate the incident command structure in the plan.</p><p>• Periodically train key personnel on the plan.</p><p>• The plan should include care of single patients (eg, Ebola) and managing large number of patients in an epidemic (eg, novel influenza).</p><p>• Incorporate communications with local and state health department officials.</p><p>Screening and signage (when appropriate based on the threat of a highly communicable disease)</p><p>• Place signs at every entrance to the hospital and clinics that includes the following: epidemiologic clues to possible disease exposure (ie, travel locations), signs and symptoms of infection, and who to notify if the patient or visitor has both exposure and appropriate signs or symptoms.</p><p>• Include messaging about the signs and symptoms of the concerning disease in all telephone contacts with the patient (eg, reminders about appointments) and who to contact prior to arrival at the health care facility.</p><p>• Screen all patients immediately at the time of all health care visits.</p><p>• Include screening in the electronic medical record (also have alerts in the medical record that require screening).</p><p>• Place an appropriate isolation sign on the door of all patients being isolated because of the possibility of a highly communicate disease.</p><p>• For diseases transmitted via the droplet or airborne routes emphasize respiratory hygiene (ie, immediate use of a mask and proper disposal of tissues).</p><p>• Emphasize the need for proper hand hygiene.</p><p>• All messaging should be in appropriate languages for the region.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Triage</head><p>• Train frontline person in all clinics and the emergency department in appropriate use of personal protective equipment.</p><p>• Have appropriate personal protective equipment available.</p><p>• Have a designated location in the emergency department and all clinics in which to immediately place the patient (a private room; ideally with access to a sink and toilet, and if possible, one that meets standards for a disease transmitted by the airborne route (ie, negative pressure, out-exhausted air, &gt;12 air exchanges per hour) if applicable.</p><p>• For diseases transmitted by the airborne route and when an airborne isolation room is not available, ideally place a portable high-efficiency particulate air purifier in the room.</p><p>• Have a well-defined process for alerting key health care facility officials about the presence of a patient with a possible highly communicative disease (eg, disaster manager, infection preventionist).</p><p>• Avoid blood tests or other procedures that may place the laboratory staff or other health care personnel at risk.</p><p>• Have a well-defined and safe method for transporting a patient either to a properly equipped emergency department or hospital facility able to safely care for a patient. Inpatient care</p><p>• Have a well-defined plan for the inpatient location that will provide care to a patient with a highly communicative disease (or a plan for transporting such a patient to facility that can provide such care).</p><p>• In the inpatient care unit designate areas that are hot (ie, potentially contaminated) and cold (ie, areas that are not contaminated).</p><p>• Have a well-trained medical care team. For highly communicable diseases (eg, Lassa, Ebola), ideally provide 3-step training: (1) basic individual training on personal protective equipment donning and doffing (and including how to manage contamination of the environment from a spill and breach of the personal protective equipment. Such training should be individualized to the specialty of the health care providers [ie, physician, nurse, respiratory therapist]); (2) team training using mannequins; and (3) team training in the designated containment unit.</p><p>• Train team personnel on donning and doffing using an explicit written list of all donning and doffing steps.</p><p>• Screen and exclude health care personnel unable to wear the proper personal protective equipment. Consider excluding from the care team personnel at high risk for disease acquisition or more severe illness, such as persons with nonintact skin, pregnancy, and immunocompromised persons. Consider excluding trainees from providing care.</p><p>• Store an adequate supply of personal protective equipment.</p><p>• If needed, have dedicated point of care laboratory equipment.</p><p>• Develop a method to safely dispose of solid and liquid wastes.</p><p>• Restrict visitors (if indicated) and maintain a log of all visitors.</p><p>• Maintain a log of all health care personnel providing care.</p><p>• Develop a plan for managing health care personnel with unprotected exposure to the infectious agent (eg, needlestick).</p><p>• Assure that care team members receive proper rest. e95</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>D.J. Weber et al. / American Journal of Infection Control 44 (2016) e91-e100</head><p>approximately 24 outbreaks have occurred. <ref type="bibr" target="#b58">59</ref> The current outbreak, which began in 2014 in West Africa, has involved Guinea, Sierra Leone, and Liberia. Cases were also reported in Nigeria, <ref type="bibr">Senegal</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical manifestations</head><p>EVD is characterized by the sudden onset of fever, headache, myalgias, arthralgias of the large joints, and back pain. <ref type="bibr" target="#b56">57,</ref><ref type="bibr" target="#b61">62</ref> Typically, 2-3 days after the initial symptoms, gastrointestinal symptoms occur, including abdominal pain, nausea, vomiting, and diarrhea. A macular or maculopapular skin rash may appear on days 5-7 of the disease. Hemorrhage is less common, occurring in only 15%-20% of patients. Terminal cases develop disseminated intravascular coagulation, septic shock, and multiorgan system failure.</p><p>Mortality ranges from 40%-90% and depends in part on the infecting species. The Zaire species has the highest mortality (up to 90%) followed by the Sudan species (approximately 50%); Bundibugyo species (approximately 40%), the Tai Forest species has a low mortality (although only a single infected person has been reported) and the Reston species causes subclinical infection in humans. Pregnant women have a higher mortality.</p><p>Diagnostic testing is achieved with the use of real-time PCR on blood. Viral RNA is usually detectable by PCR between 3 and 10 days after the onset of symptoms. Therefore, early in the course of illness, diagnostic tests may be falsely negative. There are currently no approved therapies for Ebola; however, there are investigational therapies, including immunoglobulins from recovered patients, humanized monoclonal antibodies produced transgenically by using the Nicotiana benthamiana plant, and a number of antiviral agents, including adenosine analogues, viral RNA-dependent RNA polymerase inhibitors, and short interfering RNA. <ref type="bibr" target="#b62">63,</ref><ref type="bibr" target="#b63">64</ref> Additionally, multiple vaccine platforms have been developed with some in clinical trials.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Infection control issues</head><p>The high mortality of Ebola coupled with the low inoculated dose required to initiate infection has led to a massive public health response in the United States, including screening by public health personnel of persons returned from epidemic countries in West Africa, development of specialized Ebola treatment centers, and training of thousands of HCP in the use of specialized PPE to minimize the risk of Ebola acquisition during patient care. Detailed recommendations on screening for Ebola among potentially infected returned travelers and management of patients with EVD are available on the CDC Web pages and in published articles. <ref type="bibr" target="#b64">[65]</ref><ref type="bibr" target="#b65">[66]</ref><ref type="bibr" target="#b66">[67]</ref> Given the high volume of diarrhea and vomiting and the potential for fomite transmission, environmental control is a critical issue in the care of an Ebola-infected patient. Ebola virus may persist on steel and plastic surfaces for &gt;7 days. <ref type="bibr" target="#b67">68,</ref><ref type="bibr" target="#b68">69</ref> It may also persist in liquid media for prolonged periods. Sodium hypochlorite (0.5% and 1%) sterilized surfaces within 5 minutes, and 67% ethanol sterilized carriers at 5 minutes. <ref type="bibr" target="#b67">68</ref> A &gt;4 log10 reduction of an Ebola strain was achieved in 15 seconds using the following povidone iodine solutions: 4%, 7.5%, 10%, and 3.2% iodine with 78% alcohol. <ref type="bibr" target="#b69">70</ref> Consistent use of appropriate PPE with strict adherence to donning and doffing protocols is crucial to preventing acquisition of EVD during patient care. <ref type="bibr" target="#b64">[65]</ref><ref type="bibr" target="#b65">[66]</ref><ref type="bibr" target="#b66">[67]</ref> A key component of reducing HCP risk is proper training in PPE donning and doffing with ongoing training to maintain competency.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SARS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Microbiology</head><p>SARS was caused by a novel coronavirus, SARS-CoV, that was phylogenetically distinct from all previously known human and animal coronaviruses. <ref type="bibr" target="#b70">71</ref> As with other coronaviruses, SARS-CoV is a positivestrand RNA virus belonging to the family Coronaviridae. <ref type="bibr" target="#b71">72</ref> It is classified as lineage 2B β CoV.</p><p>SARS-CoV-like viruses were detected in Himalayan palm civets and a raccoon dog in a market in Southern China. The ultimate reservoir is felt to be the Chinese horseshoe bat (Rhinolophus sinicus).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Epidemiology</head><p>The incubation period for SARS was 4.6 days, whereas the mean time from symptom onset to hospitalization was 2-8 days. <ref type="bibr" target="#b72">73</ref> Humanto-human transmission occurred most commonly via the droplet route. SARS was also transmitted via contact (direct and indirect). Airborne transmission may have occurred during aerosol generating procedures.</p><p>The attack rate for SARS-CoV ranged from 10%-60% or 2.4-31.3 cases per 1,000 exposure hours. <ref type="bibr" target="#b73">74</ref> Importantly, some patients appeared to be superspreaders, with some cases transmitting SARS to &gt;100 contacts.  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Outbreaks</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SARS first appeared in Southern China in</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical manifestations</head><p>SARS generally began with a high fever (temperature &gt;38.8°C) and included headache and myalgias. Some people had mild respiratory symptoms at the onset of illness. After 2-7 days, most patients developed a dry cough. Diarrhea was present in 10%-20% of cases. Laboratory abnormalities included lymphopenia, slightly decreased platelet counts, prolonged coagulation profiles, and mildly elevated serum hepatic enzymes. <ref type="bibr" target="#b70">71</ref> Overall mortality was 9.6%. Risk factors for death included age &gt;60 years, diabetes mellitus, hepatitis B infection, and higher viral load.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>74,76</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Infection control issues</head><p>The SARS epidemic exposed global weakness in infection control practices. Overall, approximately 21% of infected persons were HCP, but some areas, such as Hong Kong and Hanoi, experienced higher rates of HCP infection (46% and 63%, respectively). <ref type="bibr" target="#b74">75</ref> The infection control lessons learned from SARS have been reviewed. <ref type="bibr" target="#b75">[76]</ref><ref type="bibr" target="#b76">[77]</ref><ref type="bibr" target="#b77">[78]</ref><ref type="bibr" target="#b78">[79]</ref><ref type="bibr" target="#b79">[80]</ref> The risk of developing SARS was 12.6 times higher for those that did not wear a mask during patient care activities. <ref type="bibr" target="#b75">76</ref> Other risk factors for acquisition of infection by health care providers included contact with respiratory tract secretions; exposure to body fluids of health care providers' eyes and mucous membranes; inconsistent use of goggles, gowns, and caps; and performing aerosol-generating procedures (intubation, manual ventilation, chest physiotherapy, and suctioning). <ref type="bibr" target="#b75">76</ref> Inadequate patient placement in proper isolation rooms was also a risk for nosocomial transmission. Handwashing was shown to be protective in multiple studies. <ref type="bibr" target="#b80">81</ref> SARS-CoV was shown to survive in diarrheal stool samples for 4 days and in respiratory tract secretions for &gt;7 days at room temperature. <ref type="bibr" target="#b81">82</ref> Human coronavirus (HCoV 229E) was inactivated within 1 minute by 2% glutaraldehyde, multiple quaternary ammonium compounds, and multiple phenolics. <ref type="bibr" target="#b82">83</ref> Using human coronavirus (HCoV229E), Sizun et al demonstrated survival of the viruses on aluminum, sterile sponges, or latex surgical gloves for &gt;6 hours. <ref type="bibr" target="#b83">84</ref> Using transmissible gastroenteritis virus as a surrogate for SARS, survival on isolation gowns was documented up to 24 hours postinoculation. <ref type="bibr" target="#b84">85</ref> Data on inactivation of coronaviruses come primarily from work with HCoV 229E, in which this virus is inactivated within 1 minute by 2% glutaraldehyde, multiple quaternary ammonium compounds, and multiple phenolics. <ref type="bibr" target="#b82">83</ref> It can also be inactivated within 1 minute by 10% povidone-iodine, 0.05% chlorhexidine gluconate, and 70% alcohol. <ref type="bibr" target="#b82">83</ref> SARS-CoV was inactivated using a 5-minute exposure time by 1:100 hypochlorite. <ref type="bibr" target="#b81">82</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MERS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Microbiology</head><p>The MERS is a new viral respiratory disease of humans first described in 2012 and caused by a novel coronavirus (lineage 2C β CoV). <ref type="bibr" target="#b85">[86]</ref><ref type="bibr" target="#b86">[87]</ref><ref type="bibr" target="#b87">[88]</ref><ref type="bibr" target="#b88">[89]</ref> The microbiology, epidemiology, and clinical manifestations of SARS and MERS have been compared.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>72,90-92</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Epidemiology</head><p>As of September 25, 2015, the following countries in the Middle East have reported cases: Iran, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates, and Yemen. Countries with travel-associated cases have included Algeria, Austria, China, Egypt, France, Germany, Greece, Italy, Malaysia, Netherlands, Philippines, Republic of Korea, Thailand, Turkey, United Kingdom, and the United States. The United States has had only 2 travel-associated cases, both of whom were health care providers who lived and worked in Saudi Arabia. <ref type="bibr" target="#b86">87</ref> No person-to-person transmission has been documented in the United States.</p><p>MERS-CoV is a zoonotic disease that it transmitted from animals to humans. The origins of the virus are not fully understood, but it is believed to have originated in bats and then transmitted to camels. Currently, it is believed that dromedary (single-humped) camels are a major reservoir host for MERS-CoV and an animal source for humans.</p><p>MERS may be transmitted from person to person. This occurs most commonly when there is close contact, such as providing unprotected care to an infected patient. Thus far, no sustained community transmission has been documented. The R0 for MERSCoV is generally estimated to be &lt;0.7, making sustained transmission unlikely unless it mutates. <ref type="bibr" target="#b90">91</ref> Studies of family clusters and HCP contacts of patients have reported low frequencies of transmission (ie, 1%-3%). <ref type="bibr" target="#b92">93</ref> However, increased transmission has occurred in health care settings with limited infection control procedures.</p><p>The incubation period of MERS is approximately 5 days (range, 2-15 days).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Outbreaks</head><p>MERS has been epidemic in the Middle East in recent years. As of September 11, 2015, the World Health Organization has reported a total of 1,583 confirmed cases of MERS, with 566 deaths.</p><p>In the summer of 2015, a large outbreak of MERS was reported in the Republic of Korea and China. As of <ref type="bibr">September 11, 2015</ref>, the World Health Organization reported that this outbreak involved 186 total confirmed cases (Republic of Korea: n = 185; China: n = 1), with 36 deaths. The last case of MERS infection in the Republic of Korea that was reported to the World Health Organization was on July 4, 2015.</p><p>Clusters of cases have been reported in households and in health care facilities, especially when infection prevention and control practices have been inadequate. <ref type="bibr" target="#b93">94</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical manifestations</head><p>The clinical spectrum of MERS infection ranges from asymptomatic or mild respiratory symptoms to severe acute respiratory disease and death. Typical symptoms of MERS include fever, cough, and shortness of breath. Pneumonia is common but not always present. Gastrointestinal symptoms (vomiting and diarrhea) frequently occur.</p><p>Risk factors for more severe disease include older age, comorbidities (eg, chronic lung diseases, diabetes), and immunosuppression. The reported mortality is approximately 36%.</p><p>Currently, there are no specific therapies or vaccines available.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Infection control issues</head><p>Multiple outbreaks of MERS have involved health care facilities. <ref type="bibr" target="#b90">91,</ref><ref type="bibr" target="#b92">93,</ref><ref type="bibr" target="#b94">[95]</ref><ref type="bibr" target="#b95">[96]</ref><ref type="bibr" target="#b96">[97]</ref> One outbreak involved 23 patients receiving hemodialysis in an intensive care unit; the case fatality rate was 65%. In the recent outbreak in South Korea, substantial transmission was reported in health care facilities. <ref type="bibr" target="#b97">98,</ref><ref type="bibr" target="#b98">99</ref> For example, a hospital reported a single primary case, 25 secondary cases, and 11 tertiary cases. <ref type="bibr" target="#b97">98</ref> HCP have been at high risk of acquiring MERS. Al-Tawfiq and Perl reported that of 952 cases reported in Saudi Arabia (June 2012-September 2014), approximately 27% were HCP. Factors contributing to intrahospital transmission include: (1) initial symptoms of MERS are nonspecific leading to a failure to isolate the patient; (2) inadequate compliance with infection control practices; (3) inadequate health care facilities (eg, overcrowding, close proximity of patients to cases); (4) use of aerosol-generating procedures; and <ref type="formula">(5)</ref> prolonged viral shedding. <ref type="bibr" target="#b92">93</ref> Per the CDC, key methods for preventing transmission of MERS in health care facilities include notifying patients to call before arrival at a health care facility if they have had travel to the Middle East plus signs and symptoms of MERS; strict adherence to respiratory hygiene in clinics and the emergency department; early identification of possible patients; and prompt institution of contact and airborne isolation for possible cases. <ref type="bibr" target="#b99">100</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Similarities and differences between SARS and MERS</head><p>Similarities include the following: caused by coronaviruses of animal origin; severe respiratory disease; global spread through infected travelers; no effective therapies or vaccines; disease transmission to family and HCP; and infection control in health care facilities plays a critical role in limiting transmission. <ref type="bibr" target="#b86">87</ref> Differences include the following: no evidence of sustained human-to-human transmission of MERS-CoV; limited evidence of superspreaders of MERS; slower global spread of MERS, likely because of lower infectivity; and higher mortality of MERS compared with SARS (may be an artifact of ascertainment). environmental surfaces for a sufficient time to allow fomite transmission. <ref type="bibr" target="#b101">102</ref> Studies on inactivation of SARS-CoV (previously discussed) and other coronaviruses are inactivated within 1 minute by phenolics (1.3-2.0 log10 reduction) and 70% ethanol (3.2-3.9 log10 reduction). <ref type="bibr" target="#b102">103</ref> Hypochlorite with a 1:00 dilution, had a 1 minute decrease of &lt;1 log10.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Novel influenza A viruses</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p>Influenza A viruses are negative-sense RNA-enveloped viruses which belong to the Orthomyxoviridae family and are the causative agents of influenza, a contagious respiratory viral disease of birds and humans. <ref type="bibr" target="#b103">104,</ref><ref type="bibr" target="#b104">105</ref> Influenza A viruses are subdivided into distinct serotypes based on the genetic and antigenic properties of their hemagglutinin and neuraminidase, the envelope glycoproteins expressed on the surface of virus particles which are responsible for virus binding to relevant hosts and releasing newly formed infectious virions, respectively. <ref type="bibr" target="#b104">105</ref> Sixteen hemagglutinin and 9 neuraminidase subtypes have been detected in wild aquatic birds and poultry throughout the world, whereas new strains (H17-18 and N10-11) have been identified in bat species. <ref type="bibr" target="#b104">105</ref> Influenza A viruses exhibit drift each year (minor changes) and occasional shifts (major changes) which lead to pandemics. Influenza pandemics are relatively rare; there have been only 4 in the last 100 years. Multiple influenza A pandemics are likely to have occurred in the last 4 centuries, including 3 in the 18th century, 4 in the 19th century, 3 in 20th century, and 1 in the 21st century. <ref type="bibr" target="#b105">106</ref> The first pandemic of the 20th century occurred in 1918 because of the novel A(H1N1) influenza virus, followed by pandemics in 1957 because of A(H2N20), 1968 because of A(H3N2), and 2009 because of novel A(H1N1). <ref type="bibr" target="#b106">107</ref> In addition, influenza A(H1N1) was reintroduced in 1977, which may have been caused by a laboratory release. In the era before 1977, there was only a single circulating strain of influenza causing seasonal influenza in humans. Since 1977, both A(H1N1) and A(H3N2) have circulated.</p><p>Avian influenza (bird flu) is an infectious disease of birds caused by influenza A strains. The infection may cause disease in birds ranging from mild illness, which may pass unnoticed, to a rapidly fatal disease that can cause severe epidemics. Multiple subtypes of influenza A of avian origin have been reported to cause human disease in recent years, including H5N1, H6N1, H7N2, H7N3, H7N7, H7N9, H9N2, H10N7, and H10N8. <ref type="bibr" target="#b104">105,</ref><ref type="bibr" target="#b107">[108]</ref><ref type="bibr" target="#b108">[109]</ref><ref type="bibr" target="#b109">[110]</ref><ref type="bibr" target="#b110">[111]</ref> Of these, H5N1, H7N2, and H7N3 have been responsible for human infections in North America.</p><p>Influenza pandemics (outbreaks that affect a large proportion of the world because of a novel virus) are unpredictable but recurring events that can have health, economic, and social consequences worldwide. An influenza pandemic occurs when key factors converge: an influenza virus emerges with the ability to cause sustained human-to-human transmission, and the human population has little to no immunity against the virus. With the growth of global trade and travel, a localized epidemic can transform into a pandemic rapidly, with little time to prepare a public health response. <ref type="bibr" target="#b111">112</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Avian influenza A subtypes with pandemic potential</head><p>Based on the number of cases reported and duration over which these subtypes have been isolated, H5N1 <ref type="bibr" target="#b112">[113]</ref><ref type="bibr" target="#b113">[114]</ref><ref type="bibr" target="#b114">[115]</ref> and H7N9 <ref type="bibr" target="#b112">113,</ref><ref type="bibr" target="#b113">114,</ref><ref type="bibr" target="#b115">[116]</ref><ref type="bibr" target="#b116">[117]</ref><ref type="bibr" target="#b117">[118]</ref> are the most likely viruses to cause a new worldwide pandemic. has spread from Asia to Europe and Africa and has become entrenched in poultry in some countries. To date it has been reported in 16 countries, infected &gt;500 persons with a reported mortality of approximately 60%. The incubation period for A(H5N1) is generally 2-8 days (maximum, 17 days), which is much longer than the 2-to 3-day incubation period for normal seasonal influenza. Other known H5 subtypes include H5N2, H5N3, H5N4, H5N5, H5N6, H5N7, H5N8, and H5N9.</p><p>The A(H7N9) virus subtype, is a low pathogenic influenza virus, which first infected a few residents of Shanghai in March 2013. No cases of A(H7N9) have been reported outside of China. Other known H7 subtypes include H7N1, H7N2, H7N3, H7N5, H7N6, H7N7, and H7N8. In humans, H7N2, H7N3, and H7N7 have caused mild to moderate illness. H7H3 and H7N7 have caused mild to severe and fatal illness. To date, &gt;100 human cases of infection have been reported with a high mortality. The incubation period for A(H7N9) is approximately 5 days (range, 2-8 days).</p><p>Initial symptoms of A(H5N1) and A(H7N9) include high fever, usually with a temperature &gt;38 o C, and other influenza-like symptoms (cough or sore throat). Early symptoms may include diarrhea, vomiting, abdominal pain, chest pain, and bleeding from nose or gums. Characteristically, patients will develop lower respiratory tract symptoms early, including respiratory distress and a hoarse voice. Complications include hypoxemia, multiple organ dysfunction, and secondary bacterial infections. The case fatality rate is much higher than that of seasonal influenza.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Infection control</head><p>Avian influenza viruses are transmitted by close contact with infected poultry. All hospitals should have plans in place to deal with epidemic or pandemic influenza, especially if the influenza strain is both highly pathogenic for humans and easily spread from person to person. <ref type="bibr" target="#b118">[119]</ref><ref type="bibr" target="#b119">[120]</ref><ref type="bibr" target="#b120">[121]</ref> Influenza is transmitted by contact and droplet routes. It is recommended to place patients with highly pathogenic influenza viruses in hospital rooms meeting airborne isolation requirements. HCP should wear gloves, an isolation gown, an N95 respirator (or powered air purifying respirator), and eye goggles or face shield while providing care.</p><p>A(H5N1) placed on galvanized metal or glass persisted &lt;1 day at room temperature and with low or high humidity. <ref type="bibr" target="#b121">122</ref> However, at low temperatures (&lt;10°C), A(H5N1) persisted for up to 13 days. A(H5N1) was susceptible to hypochlorite solutions with 15 seconds. <ref type="bibr" target="#b122">123,</ref><ref type="bibr" target="#b123">124</ref> Currently, circulating influenza A strains are susceptible to the neuraminidase inhibitors, including A(H5N1). <ref type="bibr" target="#b124">125</ref> However, because circulating strains of A(H1N1) in 2008 exhibited resistance, one must be concerned that in the future, circulating influenza strains may develop resistance to neuraminidase inhibitors. Vaccines are available for A(H5N1) but not for A(H7N9).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONCLUSIONS</head><p>Over the last several decades, we have witnessed the emergence of many new infectious agents, some of which are major public threats. All health care facilities need to have policies and plans in place for early identification of patients with a highly communicable disease, immediate isolation, and proper management to prevent transmission to HCP, other patients, and visitors to the health care facility.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc>November 2002 and was recognized as a global threat in March 2003 when it spread to 33 countries or regions on 5 continents and was contained by July 2013. 75 SARS re-emerged in late 2003 and early 2004 in South China after resumption of wild animal trading activities in markets. There have been no reported cases since 2004. Overall, 8,098 people world- wide became ill with SARS, of which 774 died (case fatality rate = 9.6%). In the United States, only 8 persons had laboratory ev- idence of SARS-CoV infection. Independent risk factors of superspreading nosocomial out- breaks included minimum distance between beds &lt;1 m (odds ratio [OR], 6.98); washing or changing facilities for staff (OR, 0.12); per- formance of resuscitation (OR, 3.81); staff working while experiencing symptoms (OR, 4.30); SARS patients requiring oxygen therapy (OR, 4.30); and SARS patients requiring noninvasive positive pressure ven- tilation (OR, 11.82).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc>Most human cases of A(H5N1) and A(H7N9) infection have been asso- ciated with direct or indirect contact with infected live or dead poultry. The A(H5N1) virus subtype, a highly pathogenic influenza A virus, first infected humans in 1997 during a poultry outbreak in Hong Kong. Since its widespread emergence in 2003 and 2004, A(H5N1)</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0" validated="false"><head>Table 1</head><label>1</label><figDesc>Selected emerging diseases of infection control importanceHCP, health care personnel; MERS, Middle East respiratory syndrome; SARS, severe acute respiratory syndrome; vCJD, variant Creutzfeldt-Jakob disease. *Infection via a needlestick theoretically possible.</figDesc><table>Disease (initial 
location) 
Cases (United States) 
Outcome 

Person-to-person 
transmission 

Patient-to-HCP 
transmission 

Infection 
control risk 
Year 

Legionnaires' disease 
Unknown (thousands) 
Endemic and epidemic 
No 
No 
High 
1976-present 
HIV (Africa) 
Millions (thousands) 
Ongoing epidemic 
Yes (blood exposure, organ 
transplantation, vertical, sexual) 

Yes (blood exposure) 
Moderate 
1978-present 

vCJD 
Hundreds 
Controlled 
Yes (blood, theoretically via 
contaminated medical 
instruments) 

No 
Low 
1996 

West Nile fever 
(Thousands) 
Endemic 
Yes (blood transfusions, vertical, 
organ transplantation) 

No* 
Low 
1999 

SARS (China)~8,000 (8) 
Controlled 
Yes (droplet, contact, airborne?) 
Yes 
High 
2003-2004 
Monkeypox (Africa) 
(37 confirmed, 10 
probable) 

Eliminated in United 
States 

Yes (droplet, contact) 
Yes  † 
High 
2003 

MERS (Middle East) 
Thousands (2) 
Controlled 
Yes (droplet, contact) 
Yes 
High 
2014-present 
Ebola (West Africa) 
Thousands (4) 
Controlled United 
States, reduced Africa 

Yes (contact, sexual) 
Yes 
High 
2014-present 

</table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1" validated="true"><head>Table 2</head><label>2</label><figDesc>Key considerations in assessing and managing the threat of an emerging infectious disease in health care facilities Pathogen • Taxonomy (provides clues regarding transmission routes, environmental stability, germicide susceptibility)</figDesc><table>• Hosts 

Epidemiology 

• Locations of endemicity (ie, locations in the world where sources or 

reservoirs reside) 

• Incubation period 
• Transmission routes 
• Infectivity (ie, communicability) 
• Duration of infectivity 

Clinical 

• Symptoms 
• Signs 
• Risk factors for acquisition of infection 
• Morbidity 
• Mortality 
• Risk factors for morbidity and mortality 
• Diagnostic methods (sensitivity, specificity, biosafety) 
• Therapy (availability, efficacy, safety) 

Infection control 

• Environmental survival 
• Germicide susceptibility 
• Isolation recommendations 
• Recommended personal protective equipment 
• Pre-exposure prophylaxis (availability, efficacy, safety) 
• Postexposure prophylaxis (availability, efficacy, safety) 
• Recommended biosafety level in the laboratory 
• Recommended waste disposal (liquids and solids) </table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2" validated="false"><head>Table 3</head><label>3</label><figDesc>Key infection control information for selected highly communicable emerging infectious diseases</figDesc><table>Characteristic 
Lassa fever 
Ebola virus disease 
MERS 
SARS 
Novel influenza A 

Virus 
Year identified 
1969 
1976 
2012 
2003 
Family 
Arenaviridae 
Filoviridae 
Coronaviridae 
Coronaviridae 
Orthomyxoviridae 
Genome 
RNA 
RNA 
RNA 
RNA 
RNA 
Coat 
Enveloped 
Enveloped 
Enveloped 
Enveloped 
Enveloped 
Epidemiology 
Endemic location 
West Africa 
West and Central Africa 
Middle East 
China 
Worldwide (location 
varies with strain) 
Prevalence 
100,000-300,000 cases per 
year 

No recent human cases 
Varies by strain 

Reservoir 
Rodent (rat) 
Bats (fruit) 
Bats, camels 
(intermediate host) 

Bats, palm civet 
Migratory birds, pigs 

Transmission 
Inhalation, ingestion, contact 
(nonintact skin) 

Contact (nonintact skin, 
mucous membranes, 
sexual) 

Droplet, contact, airborne Inhalation, contact 

Incubation period (d) 
10 (range, 6-21) 
6-12 (range, 2-21) 
2-15 
2-14 (range, 2-21) 
Varies by strain 
Infectivity, Rho 
Not determined 
1.5-2.0 
0.3-1.3 
2.2-3.7 (range, 0.3-4.1) 
Varies by strain 
Duration, maximum (d) 
28 
21 
Case fatality rate 
15%-20%, hospitalized 
patients~5 

0% (range, 25%-90%) 
&gt;35%~10% 

Biologic safety 
Biothreat level 
A 
A 
Not specified 
C 
C (some strains) 
Biosafety level 
4 
4 
3 
3 
2-3 
Clinical 
Therapy 
Ribavirin 
Supportive 
Supportive 
Supportive 
Neuraminidase 
inhibitors 
Infection control 
Isolation 
Contact, droplet, airborne for 
aerosol-generating 
procedures 

Contact, droplet, airborne for 
aerosol-generating 
procedures 

Contact, airborne 
Contact, airborne 
Droplet, airborne for 
aerosol-generating 
procedures 
Pre-exposure prophylaxis, 
vaccine 

No 
No 
No 
No 
Yes (some strains) 

Postexposure prophylaxis 
No 
No 
No 
No 
Yes (antivirals) 

e94 
D.J. Weber et al. / American Journal of Infection Control 44 (2016) e91-e100 

</table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3" validated="false"><head></head><label></label><figDesc>, Spain, Mali, United Kingdom, Italy, and the United States. As of Sep- tember 24, 2015, there have been 28,355 total cases (15,235 laboratory-confirmed cases) and 11,311 deaths (case fatality rate, approximately 40%). Moreover, for the first time, Ebola has crossed international boundaries, involving Nigeria and Mali, and crossed continents into Europe and North America. Four cases have been acquired in the United States.</figDesc><table></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="87">MERS-CoV has been shown to be recoverable after 48 hours on steel or plastic washers (20°C and 40% relative humidity). 101 Further, no decrease in stability was observed during aerosolization experiments. This study, studies on SARS-CoV (discussed previously), and studies on other coronaviruses suggest that they survive on e97 D.J. Weber et al. / American Journal of Infection Control 44 (2016) e91-e100</note>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Bristol</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Obituary</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>William</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Stewart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">372</biblScope>
			<biblScope unit="page">110</biblScope>
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">On the exoneration of Dr. William H. Stewart: debunking an urban legend</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Spellberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Taylor-Blake</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Dis Poverty</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">3</biblScope>
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Legionnaires&apos; disease: description of an epidemic of pneumonia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">W</forename><surname>Fraser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">R</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Orenstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">E</forename><surname>Parkin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">J</forename><surname>Beecham</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">G</forename><surname>Sharrar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">297</biblScope>
			<biblScope unit="page" from="1189" to="97" />
			<date type="published" when="1977" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Legionnaires&apos; disease: isolation of a bacterium and demonstration of its role in other respiratory disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">E</forename><surname>Mcdade</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">C</forename><surname>Shepard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">W</forename><surname>Fraser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">R</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Redus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">R</forename><surname>Dowdle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">297</biblScope>
			<biblScope unit="page" from="1197" to="203" />
			<date type="published" when="1977" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Centers for Disease Control and Prevention. Pneumonia-Los Angeles. MMWR Morb Mortal Wkly Rep</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="1" to="3" />
			<date type="published" when="1981" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Pneumocystis carinii pneumonia among persons with hemophilia A</title>
	</analytic>
	<monogr>
		<title level="j">Centers for Disease Control and Prevention</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="365" to="372" />
			<date type="published" when="1982" />
		</imprint>
	</monogr>
	<note>MMWR Morb Mortal Wkly Rep</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Isolation of a T-lymphotropic retrovirus from a patient at risk for Acquired Immune Deficiency Syndrome (AIDS)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Barre-Sinoussi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Chermann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Rey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">T</forename><surname>Nugeyre</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Chamaret</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Gruest</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">220</biblScope>
			<biblScope unit="page" from="868" to="71" />
			<date type="published" when="1983" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">The origin and diversity of the HIV-1 pandemic</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Hemelaar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Mol Med</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="182" to="92" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title level="m" type="main">Emerging infections: microbial threats to health in the United States</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Institute Of Medicine</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1992" />
			<publisher>National Academy Press</publisher>
			<pubPlace>Washington, DC</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<title level="m" type="main">Microbial threats to health: emergence, detection, and response</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Institute Of Medicine</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2001" />
			<publisher>National Academy Press</publisher>
			<pubPlace>Washington, DC</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<title level="m" type="main">World Health Organization. Emerging diseases</title>
		<ptr target="http://www.who.int/topics/emerging_diseases/en/.Accessed" />
		<imprint>
			<date type="published" when="2015-09-20" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title/>
		<ptr target="http://wwwnc.cdc.gov/eid/page/background-goals.Accessed" />
	</analytic>
	<monogr>
		<title level="j">Centers for Disease Control and Prevention. EID journal background and goals</title>
		<imprint>
			<date type="published" when="2015-09-20" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Travel and the emergence of infectious diseases</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">E</forename><surname>Wilson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Emerg Infect Dis</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="39" to="46" />
			<date type="published" when="1995" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Host range and emerging and reemerging pathogens</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mej</forename><surname>Woolhouse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Gowtage-Sequeria</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Emerg Infect Dis</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1842" to="1849" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Emerging pathogens: the epidemiology and evolution of species jumps</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mej</forename><surname>Woolhouse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">T</forename><surname>Haydon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Antia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Ecol Evol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="238" to="282" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Ecology of zoonoses: natural and unnatural histories</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">B</forename><surname>Karesh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Dobson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">O</forename><surname>Lloyd-Smith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Lubroth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Dixon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Bennett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="page" from="1936" to="1981" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">The origin and prevention of epidemics</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">L</forename><surname>Pike</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">E</forename><surname>Saylors</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">N</forename><surname>Fair</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Lebreton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Tamoufe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">F</forename><surname>Djoko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="1636" to="1676" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Prediction and prevention of the next pandemic zoonosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">S</forename><surname>Morse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Mazel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Woolhouse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">R</forename><surname>Parrish</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Carroll</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">B</forename><surname>Karesh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="page" from="1956" to="65" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Human viruses: discovery and emergence</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Woolhouse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Hudson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Howey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Chase-Topping</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Philos Trans R Soc Lond B Biol Sci</title>
		<imprint>
			<biblScope unit="volume">367</biblScope>
			<biblScope unit="page" from="2864" to="71" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Factors in the emergence of infectious diseases</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">S</forename><surname>Morse</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Emerg Infect Dis</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="7" to="14" />
			<date type="published" when="1995" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Public health threat or new, reemerging, and neglected zoonoses in the industrialized world</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Cutler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">R</forename><surname>Fooks</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Whm</forename><surname>Van Der Poel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Emerg Infect Dis</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Information by emerging or reemerging infectious diseases topic</title>
		<ptr target="http://www.cdc.gov/ncidod/diseases/eid/disease_sites.htm.Accessed" />
	</analytic>
	<monogr>
		<title level="j">Centers for Disease Control and Prevention</title>
		<imprint>
			<date type="published" when="2015-09-20" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Population biology of emerging and re-emerging pathogens</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mej</forename><surname>Woolhouse</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Microbiol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="3" to="7" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Temporal trends in the discovery of human viruses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mej</forename><surname>Woolhouse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Howey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Gaunt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Reilly</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Chase-Topping</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Savill</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Biol Sci</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="2111" to="2116" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Legionnaires&apos; disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">A</forename><surname>Cunha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Burillo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Bouza</surname></persName>
		</author>
		<idno>doi:10.1016/ S0140-6736</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="60078" to="60080" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
	<note>epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Variant Creutzfeldt-Jakob disease: an update</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">W</forename><surname>Ironside</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Folia Neuropathol</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="50" to="56" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">A review of the epidemiology and clinical aspects of West Nile virus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">J</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">E</forename><surname>Webb</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Gen Med</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="193" to="203" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Human monkeypox: an emerging zoonoses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Di</forename><surname>Giulio</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">B</forename><surname>Eckburg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Infect Dis</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="15" to="25" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Emerging diseases go global</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mej</forename><surname>Woolhouse</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">451</biblScope>
			<biblScope unit="page" from="898" to="907" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Methicillin-resistant Staphylococcus aureus: an evolving pathogen</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">E</forename><surname>Stryjewski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">R</forename><surname>Corey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="10" to="19" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>O&amp;apos;driscoll</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">W</forename><surname>Crank</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Drug Resist</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="217" to="247" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">A call for action: managing the emergence of multidrugresistant Enterobacteriaceae in the acute settings</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Savard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">M</forename><surname>Perl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="371" to="378" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Tangden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">G</forename><surname>Giske</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Intern Med</title>
		<imprint>
			<biblScope unit="volume">277</biblScope>
			<biblScope unit="page" from="501" to="513" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Clostridium difficile infection</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Leffler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">T</forename><surname>Lamont</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">375</biblScope>
			<biblScope unit="page" from="1539" to="1587" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Robilotti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Deresinski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">A</forename><surname>Pinsky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Norovirus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Rev</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="134" to="64" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title/>
		<ptr target="http://www.cdc.gov/mumps/outbreaks.html.Accessed" />
	</analytic>
	<monogr>
		<title level="j">Centers for Disease Control and Prevention. Mumps cases</title>
		<imprint>
			<date type="published" when="2015-09-25" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title/>
		<ptr target="http://www.cdc.gov/measles/cases-outbreaks.html.Accessed" />
	</analytic>
	<monogr>
		<title level="j">Centers for Disease Control and Prevention. Measles cases</title>
		<imprint>
			<date type="published" when="2015-09-25" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<monogr>
				<ptr target="http://www.cdc.gov/pertussis/surv-reporting/cases-by-year.html.Accessed" />
		<title level="m">Centers for Disease Control and Prevention. Pertussis cases by year</title>
		<imprint>
			<date type="published" when="2015-09-25" />
			<biblScope unit="page" from="1922" to="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Risks and prevention of nosocomial transmission of rare zoonotic diseases</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">A</forename><surname>Rutala</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="446" to="56" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Hemorrhagic fever viruses as biological weapons: medical and public health management</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Borio</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Inglesby</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">J</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">L</forename><surname>Schmaljohn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">B</forename><surname>Jahrling</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">287</biblScope>
			<biblScope unit="page" from="2391" to="405" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Foundations of the severe acute respiratory syndrome preparedness and response plan for healthcare facilities</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Srinivasan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">C</forename><surname>Mcdonald</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Jernigan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Helfand</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Ginsheimer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Jernigan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Control Hosp Epidemiol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1020" to="1025" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Protecting health care workers from SARS and other respiratory pathogens: a review of the infection control literature</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Gamage</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Copes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Yassi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Bryce</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Infect Control</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="114" to="135" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Infection control for emerging infectious diseases in developing countries and resource-limited settings</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Aprisarnthanarak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">M</forename><surname>Mundy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Control Hosp Epidemiol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="885" to="892" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Risks to healthcare workers with emerging infectious diseases: lessons from MERS-CoV, Ebola, SARS, and avian flu</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Suwantarat</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Aprisarnthanarak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="349" to="61" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Registration of disinfectants based on relative microbiocidal activity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">A</forename><surname>Rutala</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Weber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Control Hosp Epidemiol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="333" to="374" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Lassa virus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Gunther</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Lenz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Rev Clin Lab Sci</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="339" to="90" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Lassa fever: epidemiology, clinical features, and social consequence</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">K</forename><surname>Raymond</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Baglobe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">327</biblScope>
			<biblScope unit="page" from="1271" to="1276" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<monogr>
		<title level="m" type="main">Lassa fever carries little risk to public, experts say</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Grady</surname></persName>
		</author>
		<ptr target="http://www.nytimes.com/2015/05/27/science/lassa-virus-carries-little-risk-to-public-experts-say.html.Accessed" />
		<imprint>
			<date type="published" when="2015-09-25" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Viral haemorrhagic fevers in healthcare settings</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Ftika</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">C</forename><surname>Maltezou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hosp Infect</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="185" to="92" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Lassa fever: response to an imported case</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">M</forename><surname>Sweighaft</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">W</forename><surname>Fraser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maw</forename><surname>Hattwick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">G</forename><surname>Winkler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">C</forename><surname>Jordan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Alter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">297</biblScope>
			<biblScope unit="page" from="803" to="810" />
			<date type="published" when="1977" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Lassa fever in the United States</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">P</forename><surname>Holmes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Mccormick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">C</forename><surname>Trock</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Chase</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">M</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">A</forename><surname>Mason</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">323</biblScope>
			<biblScope unit="page" from="1120" to="1123" />
			<date type="published" when="1990" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Centers for Disease Control and Prevention. Imported Lassa fever-New Jersey</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="894" to="901" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
	<note>MMWR Morb Mortal Wkly Rep</note>
</biblStruct>

<biblStruct xml:id="b52">
	<monogr>
		<title level="m" type="main">Lassa fever reported in U.S. traveler returned from West Africa</title>
		<ptr target="http://www.cdc.gov/media/releases/2014/p0404-lassa-fever.html.Accessed" />
		<imprint>
			<date type="published" when="2015-09-25" />
			<publisher>Centers for Disease Control and Prevention</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Review of nosocomial Lassa fever in Nigeria: the high price of poor medical practice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">P</forename><surname>Fisher-Hoch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Tomori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Nasidi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">I</forename><surname>Perez-Oronoz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Fakile</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Hutwagner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">311</biblScope>
			<biblScope unit="page" from="857" to="866" />
			<date type="published" when="1995" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Viral haemorrhagic fevers imported into non-endemic countries: risk assessment and management</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Bannister</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br Med Bull</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="193" to="225" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">G</forename><surname>Baasch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">M</forename><surname>Hadi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">H</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jjl</forename><surname>Lertora</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="1435" to="1476" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Ebola virus disease: a perspective for the United States</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">G</forename><surname>Madariage</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="page" from="682" to="91" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Transmission of Ebola virus: an overview</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Rewar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Mirdha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Global Health</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="444" to="51" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Ebola virus disease in Africa: epidemiology and nosocomial transmission</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Shears</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Dempsey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tjd</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hosp Infect</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Ebola virus disease: a review of its past and present</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Murray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anesth Analg</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="798" to="809" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Ebola virus disease: from epidemiology to prophylaxis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">B</forename><surname>Lui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><forename type="middle">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">W</forename><surname>Cao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mil Med</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">7</biblScope>
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Ebola virus disease: essential public health principles for clinicians</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">L</forename><surname>Koenig</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Majestic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Burns</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">West J Emerg Med</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="728" to="759" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Ebola outbreak in western Africa 2014: what is going on with Ebola virus?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Na</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Yeom</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Song</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Vaccine Res</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="17" to="22" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Ebola virus infection: overview and update on prevention and treatment</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Salim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Hurtado</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">E</forename><surname>Kilgore</surname></persName>
		</author>
		<idno>doi:10.1007/ s40121-015-0079-5</idno>
	</analytic>
	<monogr>
		<title level="j">Infect Dis Ther</title>
		<imprint>
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Ebola virus disease: what clinicians in the United States need to know</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">M</forename><surname>Uyeki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">V</forename><surname>Tauxe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Infect Control</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="788" to="93" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Protecting healthcare personnel from acquiring Ebola virus disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Wohl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">A</forename><surname>Rutala</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Control Hosp Epidemiol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="1229" to="1261" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Ebola virus disease: preparedness and infection control lessons from two biocontainment units</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">L</forename><surname>Hewlett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Varkey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">W</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">S</forename><surname>Ribner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="343" to="351" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Evaluating environmental persistence and disinfection of the Ebola virus Makona variant</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bwm</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">A</forename><surname>Cutts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Nikiforuk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">G</forename><surname>Poliquin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Court</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">E</forename><surname>Strong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Viruses</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="1975" to="86" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">The survival of filoviruses in liquids, on solid substances and in a dynamic aerosol</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">J</forename><surname>Piercy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Smither</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Steward</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Eastaugh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">S</forename><surname>Lever</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Appl Microbiol</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="1531" to="1540" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Povidone-iodine hand wash and hand rub products demonstrate excellent in vitro virucidal efficacy against Ebola virus and modified vaccinia virus Ankara, the new European test virus for enveloped viruses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Eggers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Eichmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Kowalski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Zorn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Reimer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Infect Dis</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">375</biblScope>
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Severe acute respiratory syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jsm</forename><surname>Peiris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Guan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">Y</forename><surname>Yuen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="88" to="97" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">F</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Skp</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">W</forename><surname>To</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vcc</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pcy</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K-Y</forename><surname>Yuen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Rev</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="465" to="522" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Severe acute respiratory syndrome and coronavirus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dsc</forename><surname>Hui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pks</forename><surname>Chan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Dis Clin North Am</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="619" to="657" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Severe acute respiratory syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">D</forename><surname>Christian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">M</forename><surname>Poutanen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Loutfy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">P</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">E</forename><surname>Low</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="1420" to="1427" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Severe acute respiratory syndrome (SARS)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Cleri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">J</forename><surname>Ricketti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">R</forename><surname>Vernaleo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Dis Clin North Am</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="175" to="202" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Clinical management and infection control of SARS: lessons learned</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vcc</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jfw</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ktw</forename><surname>To</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">Y</forename><surname>Yuen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antiviral Res</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="407" to="426" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Risk of respiratory infection in health care workers: lessons on infection control emerge from the SARS outbreak</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Wilder-Smith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jgh</forename><surname>Low</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Southeast Asian J Trop Med Public Health</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="481" to="489" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Severe acute respiratory syndrome (SARS): a review</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Vijayanand</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Wilkins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Woodhead</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Med</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="152" to="60" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Lessons from severe acute respiratory syndrome (SARS): implications for infection control</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">P</forename><surname>Wenzel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Bearman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">B</forename><surname>Edmond</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Med Res</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="610" to="616" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Using an integrated infection control strategy during outbreak control to minimize nosocomial infection of severe acute respiratory syndrome among healthcare workers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M-Y</forename><surname>Yen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">E</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I-J</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">S</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">C</forename><surname>Chang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hosp Infect</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="195" to="204" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Effectiveness of handwashing in preventing SARS: a review</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">C</forename><surname>Fung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Cairncross</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trop Med Int Health</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1749" to="58" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Survival of severe acute respiratory coronavirus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Myy</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pkc</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wwl</forename><surname>Lim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="67" to="71" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Geller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Varbanov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">E</forename><surname>Duval</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Viruses</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="3044" to="68" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospitalacquired infections</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Sizun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mwn</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Talbot</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hosp Infect</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="55" to="60" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Coronavirus survival on healthcare personal protective equipment</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Casanova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">A</forename><surname>Rutala</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">D</forename><surname>Sobsey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Control Hosp Epidemiol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="560" to="561" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Middle East respiratory syndrome-coronavirus infection: an overview</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Al-Tawfiq</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Public Health</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="319" to="341" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Middle East respiratory syndrome: what clinicians need to know</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Sampathkumar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mayo Clin Proc</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="1153" to="1161" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Middle East respiratory syndrome: knowledge to date</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Alsolamy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1283" to="90" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Middle East respiratory syndrome &quot;MERSCoV&quot;: current knowledge gags</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">R</forename><surname>Banik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Khandaker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Rashid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Paediatr Respir Rev</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="197" to="202" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Assiri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Al-Tawfiq</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">A</forename><surname>Al-Rabeeah</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Al-Rabiah</forename><surname>Fa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Al-Hajjar</forename></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Al</forename><forename type="middle">-</forename><surname>Barrak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Infect Dis</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="752" to="61" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Middle East respiratory syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Zumla</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">S</forename><surname>Hui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Perlman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">386</biblScope>
			<biblScope unit="page" from="995" to="1007" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Severe acute respiratory syndrome vs. the Middle East respiratory syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">S</forename><surname>Hui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><forename type="middle">A</forename><surname>Memish</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Zumla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Pulm Med</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="233" to="274" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Middle East respiratory syndrome coronavirus in healthcare settings</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Al-Tawfiq</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">M</forename><surname>Perl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="392" to="398" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Middle East respiratory syndrome coronavirus: transmission and phylogenetic evolution</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Al-Tawfiq</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><forename type="middle">A</forename><surname>Memish</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Microbiol</title>
		<imprint>
			<biblScope unit="page" from="573" to="582" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Middle East respiratory syndrome coronavirus: update for clinicians</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">A</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">I</forename><surname>Gerber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">L</forename><surname>Swerdlow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="1686" to="1695" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Middle East respiratory syndrome: implications for health care facilities</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">C</forename><surname>Maltezou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Tsiodras</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Infect Control</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="1261" to="1266" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Hospital-associated outbreak of Middle East Respiratory Syndrome coronavirus: a serologic, epidemiologic, and clinical description</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Al-Abdallat Mm</forename><surname>Payne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">C</forename><surname>Alqasrawi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Rha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Tohme</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Abedi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="1225" to="1258" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">Epidemiologic investigation of MERS-CoV spread in a single hospital in South Korea</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">Y</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">W</forename><surname>Ryu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Yi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Euro Surveill</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="1" to="6" />
			<date type="published" when="2015-06" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">MERS outbreak in Korea: hospital-to-hospital transmission</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Ki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Epidemiol Health</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page">2015033</biblScope>
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<monogr>
		<title level="m" type="main">Interim infection prevention and control recommendations for hospitalized patients with Middle East Respiratory syndrome coronavirus (MERS-CoV)</title>
		<ptr target="http://www.cdc.gov/coronavirus/mers/infection-prevention-control.html.Accessed" />
		<imprint>
			<date type="published" when="2014-09-25" />
			<publisher>Centers for Disease Control and Prevention</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Van Doremalen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Bushmaker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">J</forename><surname>Munster</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Euro Surveill</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1" to="4" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">Effects of air temperature and relative humidity on coronavirus survival on surfaces</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">M</forename><surname>Casanova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Jeon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">A</forename><surname>Rutala</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">D</forename><surname>Sobsey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Appl Environ Microbiol</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="2712" to="2719" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">Inactivation of surrogate coronaviruses on hard surfaces by health care germicides</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">L</forename><surname>Hulkower</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">M</forename><surname>Casanova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">A</forename><surname>Rutala</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">D</forename><surname>Sobsey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Infect Control</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="401" to="408" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">Emerging influenza</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>De Wit</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ram</forename><surname>Fouchier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Virol</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1" to="6" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Zoonotic infections with avian influenza A viruses and vaccine preparedness: a game of &quot;mix and match</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pnq</forename><surname>Pascua</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">K</forename><surname>Choi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Vaccine Res</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="140" to="148" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">The influenza viruses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">W</forename><surname>Hampson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">S</forename><surname>Mackenzie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med J Aust</title>
		<imprint>
			<biblScope unit="volume">185</biblScope>
			<biblScope unit="page" from="39" to="43" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">Will there ever be a new influenza pandemic and are we prepared?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Rudenko</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Sellwood</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Herfst</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Gross</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Dingwall</surname></persName>
		</author>
		<idno>doi:10.1016/ j.vaccine.2015.08.045</idno>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<date type="published" when="2015" />
		</imprint>
	</monogr>
	<note>epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">Avian influenza virus transmission to mammals</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Herfst</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Imai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Kawaoka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ram</forename><surname>Fouchier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Top Microbiol Immunol</title>
		<imprint>
			<biblScope unit="volume">385</biblScope>
			<biblScope unit="page" from="137" to="55" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">Continuing challenges in influenza</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">G</forename><surname>Webster</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">A</forename><surname>Govorkova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">1323</biblScope>
			<biblScope unit="page" from="115" to="154" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">Emerging influenza strains in the last two decades: a threat of a new pandemic</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Trombetta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Piccirella</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Perini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Kistner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Montomoli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vaccines</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="172" to="85" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">Highly pathogenic) avian influenza as a zoonotic agent</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Kalthoff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Globig</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Beer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vet Microbiol</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="page" from="237" to="282" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title/>
		<ptr target="http://www.who.int/mediacentre/factsheets/avian_influenza/en/.Accessed" />
	</analytic>
	<monogr>
		<title level="j">World Health Organization. Avian influenza. Available</title>
		<imprint>
			<date type="published" when="2015-09-25" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">Emerging respiratory tract viral infections</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">S</forename><surname>Hui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Zumla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Pulm Med</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="284" to="92" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">Global alert to avian influenza virus infection: from H5N1 to H7N9</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Poovorawan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Pyungporn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Prachayangprecha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Makkoch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pathog Glob Health</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="217" to="240" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">Implications of global and regional patterns of highly pathogenic avian influenza virus H5N1 clades for risk management</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">U</forename><surname>Pfeiffer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Otte</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Roland-Holst</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Inui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Tung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Zilberman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vet J</title>
		<imprint>
			<biblScope unit="volume">190</biblScope>
			<biblScope unit="page" from="309" to="325" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">H7N9: preparing for the unexpected in influenza</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">B</forename><surname>Jernigan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">J</forename><surname>Cox</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Med</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="361" to="71" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">Pandemic potential of avian influenza A (H7N9) viruses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">A</forename><surname>Maher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Neumann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Kawaoka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Microbiol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="623" to="654" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">Viral lung infections: epidemiology, virology, clinical features, and management of avian influenza A(H7N9)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kkw</forename><surname>To</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jhfw</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K-Y</forename><surname>Yuen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Pulm Med</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="225" to="257" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">Pandemic influenza planning</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Iskander</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Strikas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">F</forename><surname>Gensheimer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">J</forename><surname>Cox</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">C</forename><surname>Redd</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Emerg Infect Dis</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="879" to="85" />
			<date type="published" when="1978" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b119">
	<monogr>
		<title level="m" type="main">World Health Organization. Pandemic influenza preparedness and response</title>
		<ptr target="http://www.who.int/influenza/resources/documents/pandemic_guidance_04_2009/en/.Accessed" />
		<imprint>
			<date type="published" when="2015-09-25" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">Updated preparedness and response framework for influenza pandemics</title>
	</analytic>
	<monogr>
		<title level="j">Centers for Disease Control and Prevention</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="1" to="18" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
	<note>MMWR Morb Mortal Wkly Rep</note>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">Environmental persistence of a highly pathogenic avian influenza (H5N1) virus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">W</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Chappie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">V</forename><surname>Rogers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">Z</forename><surname>Kaye</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Sci Technol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="7515" to="7535" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">The inactivation of avian influenza virus subtype H5N1 isolated from chickens in Thailand by chemical and physical treatments</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Wanaratana</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Tantiletcharoen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Sasipreeyajan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Pakpinyo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vet Microbiol</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="page" from="43" to="51" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b123">
	<analytic>
		<title level="a" type="main">Chlorine inactivation of highly pathogenic avian influenza virus (H5N1)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">W</forename><surname>Rice</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">J</forename><surname>Adcock</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Sivaganesan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">D</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">E</forename><surname>Stallknecht</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">E</forename><surname>Swayne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Emerg Infect Dis</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="1568" to="70" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main">A review of the antiviral susceptibility of human and avian influenza viruses over the last decade</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">Y</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">C</forename><surname>Hurt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scientifica (Cairo)</title>
		<imprint>
			<biblScope unit="page">430629</biblScope>
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
